【取りまとめ】2022 No.15 Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths.(原著論文等 (英文))
2022年
Igeta M, Matsui S. Blinded sample size re-estimation for comparing over-dispersed count data incorporating follow-up lengths. Stat Med. 2022 Dec 20;41(29):5622-5644.doi: 10.1002/sim.9584.
Jomoto W, Takaki H, Yamamoto S, Kanematsu A, Igeta M, Hirota S, Yamakado K. Differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma using non-contrast multiparametric magnetic resonance imaging. In Vivo. 2022 Nov-Dec;36(6):2790-2799. doi: 10.21873/invivo.13016
Ishihara M, Asakura M, Hibi K, Okada K, Shimizu W, Takano H, Suwa S, Fujii K, Okumura Y, Mano T, Tsujita K, Igeta M, Okamoto R, Suna S. Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial. EuroIntervention. 2022 Oct 7;18(8):e647-e655. doi: 10.4244/EIJ-D-22-00269.
Kidawara Y, Kadoya M, Morimoto A, Daimon T, Kakutani-Hatayama M, Kosaka-Hamamoto K, Miyoshi A, Konishi K, Kusunoki Y, Shoji T, Goda A, Asakura M, Ishihara M, Koyama H. Sleep Apnea and physical movement during sleep, but not sleep duration, are independently associated with progression of left Ventricular diastolic dysfunction: Prospective hyogo sleep cardio-autonomic atherosclerosis cohort study. J Am Heart Assoc. 2022 Oct 4;11(19):e024948. doi: 10.1161/JAHA.121.024948.
Inayama E, Yamada Y, Kishida M, Kitamura M, Nishino T, Ota K, Takahashi K, Shintani A, Ikenoue T. Effect of music in reducing pain during hemodialysis access cannulation: a crossover randomized controlled trial. Clin J Am Soc Nephrol. 2022 Sep;17(9):1337-1345.doi: 10.2215/CJN.00360122.
Kumamoto T, Ishida Y, Igeta M, Hojo Y, Nakamura T, Kurahashi Y, Shinohara H. Potential advantages of robotic total gastrectomy for gastric cancer: a retrospective comparative cohort study. J Robot Surg. 2022 Aug;16(4):959-966. doi: 10.1007/s11701-021-01328-y.
Ito S, Fuwa N, Nomura M, Daimon T, Ota S, Morishima T, Ii N, Miyati T. Intratumor hemodynamics using contrast-enhanced MRI in intra-arterial chemotherapy for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Jun;133(6):706-715. doi: 10.1016/j.oooo.2021.11.007.
Hasegawa S, Yokoi K, Okada M, Tanaka F, Shimokawa M, Daimon T, Nakano T. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2022 Jun;163(6):1940-1947.e5. doi: 10.1016/j.jtcvs.2021.07.017.
Kurajoh M, Fukumoto S, Akari S, Murase T, Nakamura T, Takahashi K, Yoshida H, Nakatani S, Tsuda A, Morioka T, Mori K, Imanishi Y, Hirata K, Emoto M. Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees. Sci Rep. 2022 Jun 18;12(1):10281. doi: 10.1038/s41598-022-11094-y.
Hirakawa A, Sato H, Igeta M, Fujikawa K, Daimon T, Teramukai S. Regulatory issues and the potential use of Bayesian approaches for early drug approval systems in Japan. Pharm Stat. 2022 May;21(3):691-695. doi: 10.1002/pst.2192.
Juri T, Suehiro K, Kanematsu R, Takahashi K, Fujimoto Y, Tanaka K, Mori T. Validation of continuous noninvasive blood pressure monitoring using error grid analysis. Anesth Analg. 2022 Apr 1;134(4):773-780.doi: 10.1213/ANE.0000000000005882.
Maeda S, Taniguchi K, Asanoi H, Toda K, Funatsu T, Kondoh H, Kainuma S, Daimon T, Sawa Y. Heterogeneous reduction in regional wall stress after aortic valve replacement for aortic regurgitation: a distinct feature from aortic stenosis. J Artif Organs. 2022 Mar;25(1):42-49. doi: 10.1007/s10047-021-01278-0.
Otani K, Watanabe T, Takahashi K, Ominami M, Nadatani Y, Fukunaga S, Hosomi S, Kamata N, Tanaka F, Nagami Y, Taira K, Kimura T, Fukumoto S, Fujiwara Y. A questionnaire-based survey on the etiopathogenesis of chronic constipation during a medical check-up in Japan. J Clin Biochem Nutr. 2022 Mar;70(2):205-211. doi: 10.3164/jcbn.21-87.
Takahashi K, Yamamoto K, Kuchiba A, Koyama T. Confidence interval for micro-averaged F 1 and macro-averaged F 1 scores. Appl Intell (Dordr). 2022 Mar;52(5):4961-4972.
Asakura M, Hibi K, Shimizu W, Fujii K, Suwa S, Okumura Y, Mano T, Igeta M, Okamoto R, Ishihara M. Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease. J Cardiol. 2022 Jan;79(1):105-109. doi: 10.1016/j.jjcc.2021.08.024.